Vitamin D Dosing for PCOS: Target Level, Dose and Time to Effect

What Vitamin D Dose Do PCOS Trials Actually Use?

Three different dosing strategies show up across the PCOS vitamin D trials, from a single weekly mega-dose to a 12-week daily regimen, because the trials were not all answering the same question. Some tested a fixed daily amount; one tested a single high weekly dose; a meta-analysis pooled both approaches. The evidence-overview page covers what each trial found on insulin markers — this page covers what each one actually dosed, and for how long.

The pattern worth noticing: the 2018 meta-analysis found HOMA-IR improved significantly at doses under 4,000 IU/day, or when vitamin D was paired with another supplement — not reliably at the higher end of the range tested. More is not simply better here; the dose-response relationship the trials describe is not linear.

One unit conversion is worth having on hand if you are comparing a US or Canadian label against a UK one: US and Canadian products are almost always labelled in IU, while UK and European labels often use micrograms (mcg), where 1 mcg equals 40 IU. A UK supplement listing “25 mcg” is the same dose as a US bottle listing “1,000 IU” — the number looks different only because the unit changed, the same way the nmol/L and ng/mL split works for the blood test itself.

What Vitamin D Level Should You Aim For With PCOS?

The target is a blood level, not a dose on a bottle, and which number counts as “enough” depends on which country’s guideline your lab follows — a gap of 25 nmol/L separates the strictest and loosest definitions of sufficiency.

Dosing to a target level is a different exercise from dosing to a fixed number of IU. A woman who tests at 15 ng/mL (37 nmol/L) needs a correction dose to close a real gap; a woman already at 28 ng/mL (70 nmol/L) needs, at most, a small maintenance amount to hold her level — the same daily IU number would either undertreat the first woman or serve no purpose for the second. That is why testing before dosing, covered below, is the sensible route rather than picking a number off a supplement label.

How Long Does Vitamin D Actually Take to Work for PCOS?

Trials ran 8 to 24 weeks, and the honest finding is that even the longer end of that range did not reliably move insulin markers. Raja-Khan’s 12-week, 12,000 IU/day trial found insulin sensitivity unchanged, with only a non-significant trend toward lower 2-hour insulin. The 2018 meta-analysis found its clearest HOMA-IR benefit specifically in trials under 4,000 IU/day or in combination with another supplement — and even there, the improvement showed up across 8- to 24-week windows, not within the first few weeks. Most clinicians recheck 25(OH)D itself 8 to 12 weeks after starting a correction dose, since that is roughly how long a new dose takes to show up in a repeat blood result; testing sooner mostly measures noise rather than progress.

Does Vitamin D Help PCOS Hair Loss?

Two case-control studies, neither of them in PCOS, found lower vitamin D in women with hair loss — no PCOS-specific trial has tested whether supplementing reverses it, and that is worth saying plainly rather than inferring an answer from adjacent research. What exists is association data in women with hair loss generally, not PCOS specifically. A small Iranian case-control study of 45 women with female pattern hair loss found significantly lower serum vitamin D3 than in 45 matched controls (P = 0.04). A much larger Chinese case-control study — 657 women with female pattern hair loss against female controls, part of a cohort of over 3,900 participants — found the same pattern: significantly lower serum 25(OH)D in the hair-loss group (P < 0.0001), alongside the same association in alopecia areata and male androgenetic alopecia.

Neither study is in PCOS, and neither is a supplementation trial. Both show an association between low vitamin D and hair loss in general populations — they do not show that supplementing vitamin D regrows hair, in PCOS or otherwise, because no trial has tested that specific intervention and measured the result. If PCOS-pattern hair loss (usually an androgen-driven process) is what brought you here, the dedicated hair-loss page covers what the androgen mechanism actually is and what has trial evidence behind it — vitamin D correction is not currently one of those things.

Testing Before You Dose: Why a Fixed Number Doesn’t Work Here

Get 25(OH)D measured before supplementing at any dose above a standard multivitamin amount. The US Institute of Medicine’s dietary reference intake sets a tolerable upper intake of 4,000 IU/day for general long-term use without monitoring; the Endocrine Society guideline allows adults with a confirmed deficiency to go higher — up to 10,000 IU/day — but only as a monitored correction protocol. The higher doses used in several trials above — up to 12,000 IU/day, or the equivalent of 60,000 IU/week — sit at or above even that supervised ceiling, which is exactly why they were run as monitored trials and are not something to replicate unsupervised from a retail bottle. Vitamin D is fat-soluble and accumulates in a way water-soluble vitamins do not, so “more, just in case” carries a real cost that a water-soluble vitamin would not: hypercalcemia and, over time, an increased risk of kidney stones.

The Endocrine Society guideline recommends either vitamin D2 or vitamin D3 for correcting a deficiency — it does not favour one over the other for that purpose. Retail supplements are more commonly sold as D3, and the distinction matters less than the number that actually gets tested: a repeat 25(OH)D result after 8 to 12 weeks tells you whether the dose and form you chose worked, regardless of which one it was.

You may see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of more than 50 organisations renamed it. Nothing about the dosing evidence above changed with the name — this article uses PCOS because that is still what most readers search.

Who This Dosing Information Won’t Help

Zero of the trials reviewed here — including the 601-woman meta-analysis — showed vitamin D restoring ovulation or fertility at any dose, so if that is the outcome you are dosing for, no placebo-controlled trial on the vitamin D evidence page supports expecting it. If you are already at or above your country’s sufficiency threshold, no trial shows that dosing further improves anything measured — pushing past sufficiency is untested, not “extra insurance.” And if hair loss is what you are trying to treat with vitamin D specifically, the two association studies above come from non-PCOS populations and neither is a supplementation trial — treating this as a hair-loss dosing plan is not something the evidence in front of us supports.

Your Next Step

Ask for a 25(OH)D test before choosing a dose, and bring the target-level table above — in whichever unit your lab uses — to that appointment rather than a number from a supplement label. For the deeper trial-evidence question of whether correcting a deficiency actually changes a PCOS outcome, the vitamin D evidence page has the full picture. The other two dosing questions in this cluster are covered in NAC dosage and side effects and magnesium dosage and timing, and the full supplements section covers what else has been tested in PCOS.